Christine’s practice focuses on mergers and acquisitions and other complex corporate transactions, including domestic and cross-border mergers and acquisitions, strategic investments and carve-out transactions. She has advised clients across a variety of industries.
Liminal BioSciences to Be Acquired by Structured Alpha
July 13, 2023
Cooley advised Liminal BioSciences, a Canada-based development-stage biopharmaceutical companylisted on Nasdaq, on its all-cash cross-border sale to Structured Alpha, a fund managed by Thomvest Asset Management
Tourmaline Bio Agrees to Merge With Talaris Therapeutics
June 22, 2023
Cooley advised Tourmaline Bio, a late-stage clinical biotechnology company, on its merger agreement with Talaris Therapeutics, including a concurrent private placement.
Cooley advised TCGplayer, an online marketplace for collectible card game enthusiasts, on its agreement to sell to global commerce company eBay. Partners Kevin Cooper and Jeff Laretto led the Cooley team advising TCGplayer.
